Praxsyn (Praxsyn) EPS (Basic) : $0.02 (TTM As of Sep. 2015)

View and export this data going back to 2007. Start your Free Trial

What is Praxsyn EPS (Basic)?

Praxsyn's basic earnings per share (Basic EPS) for the three months ended in Sep. 2015 was $0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2015 was $0.02.

Praxsyn's EPS (Diluted) for the three months ended in Sep. 2015 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2015 was $0.01.

Praxsyn's EPS without NRI for the three months ended in Sep. 2015 was $0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2015 was 0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Praxsyn EPS (Basic) Historical Data

The historical data trend for Praxsyn's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Praxsyn EPS (Basic) Chart

Praxsyn Annual Data

Trend

Oct05

Oct06

Oct07

Oct08

Oct09

Dec10

Dec11

Dec12

Dec13

Dec14

EPS (Basic)

Get a 7-Day Free Trial

-0.13

-0.18

-0.02

-0.05

Praxsyn Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
EPS (Basic)	Get a 7-Day Free Trial															-	-	-	0.01	0.01

Praxsyn EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Praxsyn's Basic EPS for the fiscal year that ended in Dec. 2014 is calculated as

Basic EPS (A: Dec. 2014 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-12.354	-	0)	/	268.949
	=	-0.05

Praxsyn's Basic EPS for the quarter that ended in Sep. 2015 is calculated as

Basic EPS (Q: Sep. 2015 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(2.969	-	0)	/	627.753
	=	0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02

Praxsyn (GREY:PXYN) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Praxsyn EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Praxsyn's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Praxsyn (Praxsyn) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Praxsyn Corp (GREY:PXYN) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

61 Spectrum Boulevard, Suite A, Las Vegas, NV, USA, 89101

Website

http://www.praxsyncorp.com

Praxsyn Corp is a healthcare company, dedicated to providing medical practitioners with medications and services for their patients. Through its retail pharmacy facility, it formulates healthcare practitioner-prescribed medications to serve patients who experience chronic pain. It primarily focuses on non-narcotic and non-habit forming medications using therapeutic and preventative agents for pain management. In addition, the group prepares innovative products that address erectile dysfunction and metabolic issues and other ancillary products. The products of the firm are either picked up directly from pharmacy facility or shipped directly to patients. The business activities are functioned through the regions of United States.